2.3 Virtue ethics and character-based decision making

Virtue ethics in biotech focuses on the moral character of individuals and organizations. It emphasizes key virtues like integrity, compassion, and responsibility in decision-making. This approach evaluates whether biotech professionals embody these virtues in their conduct and motivations.

Professional ethics codes play a crucial role in articulating core values and guiding ethical behavior. However, virtue ethics has limitations, including subjectivity and challenges in prioritizing conflicting virtues. It often requires complementary approaches for comprehensive ethical decision-making in biotechnology.

Virtue Ethics and Character-Based Decision Making

Key virtues in biotech ethics

Top images from around the web for Key virtues in biotech ethics

• 

  Freedom and Flourishing: How can the traditional virtues help people to have the basic goods of ... View original

  Is this image relevant?

• 

  Comparing the Virtue Ethics of East and West – Business Ethics View original

  Is this image relevant?

• 

  The three moral codes of behaviour | Clamor World View original

  Is this image relevant?

• 

  Freedom and Flourishing: How can the traditional virtues help people to have the basic goods of ... View original

  Is this image relevant?

• 

  Comparing the Virtue Ethics of East and West – Business Ethics View original

  Is this image relevant?

1 of 3

Top images from around the web for Key virtues in biotech ethics

• 

  Freedom and Flourishing: How can the traditional virtues help people to have the basic goods of ... View original

  Is this image relevant?

• 

  Comparing the Virtue Ethics of East and West – Business Ethics View original

  Is this image relevant?

• 

  The three moral codes of behaviour | Clamor World View original

  Is this image relevant?

• 

  Freedom and Flourishing: How can the traditional virtues help people to have the basic goods of ... View original

  Is this image relevant?

• 

  Comparing the Virtue Ethics of East and West – Business Ethics View original

  Is this image relevant?

1 of 3

• Integrity involves being honest, transparent, and trustworthy in all dealings (research, business, public communication)
• Compassion entails empathy, benevolence, and respect for human dignity when developing and applying biotech solutions (personalized medicine, assistive devices)
• Responsibility means being accountable, reliable, and committed to public welfare in the conduct of biotech activities (clinical trials, product safety)
• Courage requires the willingness to speak up against unethical practices and the fortitude to make difficult decisions (whistleblowing, resource allocation)
• Humility involves openness to feedback and criticism, as well as acknowledgment of limitations and uncertainties in biotech knowledge (peer review, informed consent)
• Prudence demands careful consideration of risks and benefits, and sound judgment in complex situations (gene editing, drug development)
• Justice entails fairness in the distribution of benefits and burdens, non-discrimination, and equal treatment in biotech access and applications (healthcare disparities, research participant selection)

Application of virtue ethics

• Focuses on the moral character of the agent rather than the consequences or duties (individual researchers, biotech companies)
• Assesses whether individuals and organizations embody and promote key virtues in their conduct and decision-making (research integrity, corporate social responsibility)
• Considers the motivations and intentions behind actions and decisions, beyond mere compliance with rules or calculation of outcomes (altruism, profit-seeking)
• Evaluates the consistency of behavior and decision-making with virtuous principles over time and across different contexts (publication bias, conflicts of interest)
• Examines the organizational culture and its influence on individual character development through socialization, incentives, and leadership (academic institutions, start-up ventures)
• Analyzes the impact of role models and leadership on fostering virtuous behavior by setting examples and creating enabling environments (mentorship, diversity and inclusion)
• Identifies potential conflicts between personal and professional virtues that may arise in biotech practice (work-life balance, client confidentiality)

Role of professional ethics codes

• Articulate the core values and principles of the biotech profession, such as beneficence, non-maleficence, autonomy, and justice (Belmont Report, Declaration of Helsinki)
• Provide guidance on ethical conduct and decision-making in various contexts, from research and development to commercialization and application (clinical trials, intellectual property, marketing)
• Serve as a framework for moral education and character development by clarifying expectations and fostering reflection and discussion (ethics training, case studies)
• Establish a shared understanding of professional responsibilities and obligations across different roles and sectors within the biotech community (scientists, engineers, managers, policymakers)
• Promote accountability and self-regulation within the biotech community by providing standards for evaluation and enforcement (peer review, accreditation, licensing)
• Enhance public trust and confidence in the integrity of biotech professionals by demonstrating commitment to ethical principles and practices (transparency, public engagement)

Limitations of virtue ethics

• Lacks a clear decision-making framework or algorithm for determining the right course of action in specific situations (moral dilemmas, trade-offs)
• Difficulty in prioritizing conflicting virtues or principles that may be relevant to a given situation (autonomy vs. beneficence, individual vs. collective interests)
• Subjectivity in determining what constitutes virtuous character or behavior, which may vary across individuals, cultures, and contexts (cultural relativism, situational ethics)
• Potential for individual differences in the interpretation and application of virtues based on personal values, experiences, and judgments (moral pluralism, moral luck)
• Limited consideration of the consequences or outcomes of actions, which may be morally relevant in evaluating the ethics of biotech practices (utilitarian considerations, risk-benefit analysis)
• Challenges in balancing individual and collective responsibilities, particularly when the virtues of different stakeholders may conflict (patient autonomy, public health)
• Insufficient attention to the role of institutional and systemic factors in shaping individual behavior and decision-making (power dynamics, resource constraints, market forces)
• Need for complementary approaches, such as deontology or consequentialism, to provide additional guidance and justification for ethical decisions in certain situations (human rights, social justice)